Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This clinical study will be a multi-center, randomized, open-label, active-controlled, parallel-group study comparing dalbavancin to standard of care (SOC) therapy in osteomyelitis.
Epistemonikos ID: 4ce5ff526533d2f81c3af63521b763f63263d5d1
First added on: May 20, 2024